Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Christos Kalafatis Insider Profile
4 Followers
Christos Kalafatis, Chief Medical Officer at Cognetivity Neurosciences, holds 1.33M shares in Cognetivity Neurosciences (Ticker: CGNSF). Most recently, Christos Kalafatis Bought $893,454 shares of Cognetivity Neurosciences on Jul 05, 2022 for an estimated value of 491.40K.
Christos Kalafatis has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Christos Kalafatis's holdings
Insider Roles
Chief Medical Officer
Roles that Christos Kalafatis holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Christos Kalafatis
Christos Kalafatis's Trading History
List of latest transactions for each holding click on a transaction to see Christos Kalafatis's performance on stock
You May Also Like
Christos Kalafatis insider profile FAQ
What is the percentage of profitable transactions made by Christos Kalafatis?
The percentage of profitable transactions made by Christos Kalafatis is ―.
What is the average return per transaction made by Christos Kalafatis?
The average return per transaction made by Christos Kalafatis is ―.
What stocks does Christos Kalafatis hold?
Christos Kalafatis holds: CGNSF stocks.
What was Christos Kalafatis’s latest transaction?
Christos Kalafatis latest transaction was an Informative Buy of $491.40K.
What was Christos Kalafatis's most profitable transaction?
Christos Kalafatis’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Christos Kalafatis's role in Cognetivity Neurosciences?
Christos Kalafatis's role in Cognetivity Neurosciences is Chief Medical Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.